CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer
Status:
Not yet recruiting
Trial end date:
2026-04-15
Target enrollment:
Participant gender:
Summary
This is a single institute, single-arm, interventional trial to evaluate the efficacy and
toxicity of concurrent chemoradiotherapy (CCRT) followed by Tegafur, Gimeracil and Oteracil
Potassium Capsules consolidation chemotherapy in patients with locally advanced cervical
cancer.